Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.
Odler B, Riedl R, Geetha D, Szpirt WM, Hawley C, Uchida L, Wallace ZS, Walters G, Muso E, Tesar V, Pusey CD, Little MA, Merkel PA, Walsh M, Jayne DRW, Kronbichler A; PEXIVAS investigators. Odler B, et al. Among authors: kronbichler a. Kidney Int. 2024 Dec 19:S0085-2538(24)00911-6. doi: 10.1016/j.kint.2024.11.029. Online ahead of print. Kidney Int. 2024. PMID: 39708998 Free article.
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
Pichler R, Fritz J, Maier S, Hassler MR, Krauter J, D Andrea D, Laukhtina E, Gust K, Mori K, Tully KH, Niedersuess-Beke D, Korber L, Spiegelberg JA, Bauernhofer T, Subiela JD, Mayr R, Kronbichler A, Moschini M, Teoh J, Pradere B, Shariat SF, Ulmer H, Mertens LS; European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Pichler R, et al. Among authors: kronbichler a. Cancer Immunol Immunother. 2024 Dec 21;74(1):30. doi: 10.1007/s00262-024-03871-7. Cancer Immunol Immunother. 2024. PMID: 39708183 Free PMC article.
Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication.
Steiger S, Li L, Bruchfeld A, Stevens KI, Moran SM, Floege J, Caravaca-Fontán F, Mirioglu S, Teng OYK, Frangou E, Kronbichler A; Immunonephrology Working Group (IWG) of the European Renal Association (ERA). Steiger S, et al. Among authors: kronbichler a. Kidney Int. 2024 Oct 28:S0085-2538(24)00732-4. doi: 10.1016/j.kint.2024.08.038. Online ahead of print. Kidney Int. 2024. PMID: 39477067 Free article. Review.
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana LF, Diaz MM, King C, Griffin S, Ramachandran R, Odler B, Eller K, Artan AS, Mirioglu S, Busch M, Schaepe M, Turkmen K, Cheung CK, Pepper RJ, Juarez GF, Pascual J, Auñón P, García-Carro C, Rodriguez A, Alberici F, Luzardo L, Chebotareva N, Schönermarck U, Fernández L, Radhakrishnan J, Guaman K, Peleg Y, Hoisnard L, Audard V, Papasotiriou M, Krnanska N, Tesar V, Hruskova Z, Bruchfeld A, Stangou M, Lioulios G, Faguer S, Ribes D, Salhi S, Windpessl M, Galešić K, Crnogorac M, Zagorec N, Mayer G, Kronbichler A; RITERM Study Team. Gauckler P, et al. Among authors: kronbichler a. J Am Soc Nephrol. 2024 Oct 16. doi: 10.1681/ASN.0000000520. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39431468 No abstract available.
Kynurenine Pathway after Kidney Transplantation: Friend or Foe?
Zakrocka I, Urbańska EM, Załuska W, Kronbichler A. Zakrocka I, et al. Among authors: kronbichler a. Int J Mol Sci. 2024 Sep 14;25(18):9940. doi: 10.3390/ijms25189940. Int J Mol Sci. 2024. PMID: 39337426 Free PMC article. Review.
Paraneoplastic Syndrome After Kidney Transplantation: Frequency, Risk Factors, Differences to Paraneoplastic Occurrence of Glomerulonephritis in the Native Kidney, and Implications on Long-Term Kidney Graft Function.
Zakrocka I, Nair G, Soler MJ, Jhaveri KD, Kronbichler A. Zakrocka I, et al. Among authors: kronbichler a. Transpl Int. 2024 Jul 25;37:12969. doi: 10.3389/ti.2024.12969. eCollection 2024. Transpl Int. 2024. PMID: 39119062 Free PMC article. Review.
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING).
C Willcocks L, Qian W, Cader R, Gatley K, Siddiqui H, Tabebisong E, Champion K, Kronbichler A, Lightstone L, Jayne D, Wilson E, Griffith M. C Willcocks L, et al. Among authors: kronbichler a. BMC Nephrol. 2024 Aug 7;25(1):253. doi: 10.1186/s12882-024-03576-0. BMC Nephrol. 2024. PMID: 39112932 Free PMC article. Clinical Trial.
Antibody-mediated podocytopathies: a disease entity that implies immunotherapy.
Kronbichler A, Barnini C, Matyjek A, Gauckler P, Bruchfeld A, Caravaca-Fontan F, Floege J, Frangou E, Mirioglu S, Moran SM, Stevens KI, Teng YKO, Steiger S. Kronbichler A, et al. Nephrol Dial Transplant. 2024 Jul 17:gfae166. doi: 10.1093/ndt/gfae166. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39020250 No abstract available.
290 results